View article

For the past decade, the pharmaceutical industry has been under pressure to improve efficiency, as rising costs outpaced the development of new pharmaceuticals.[1] A growing interest in green processes also highlights areas for possible improvements in pharmaceutical synthesis and manufacturing, where environmental impacts have been higher than for other industries.[2] Continuous manufacturing has attracted the attention of industry and academia alike by promising lower costs, greater reliability and safety, better sustainability, and novel pathways that are not otherwise accessible.[3] Recent studies have demonstrated that economic savings can be realized for certain cases by transforming a batch production into a continuous process.[4] With existing batchbased manufacturing methods, it can take up to 12 months between the start of the first synthetic step and market release of finished tablets,[5] which …